Akoya Biosciences, Inc. Annual Deferred Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Akoya Biosciences, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Akoya Biosciences, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $37K.
  • Akoya Biosciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$51K, a 246% decline from 2022.
  • Akoya Biosciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $35K.
  • Akoya Biosciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$155K, a 2314% decline from 2020.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$51K -$86K -246% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $35K +$190K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$155K -$162K -2314% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 $7K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.